Medicare billing CPT j9217,j9219,j9225 with covered diagnosis

J9217, J9219, J9225 with appropriate ICDs

For J9217 LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG (e.g., Lupron Depot®, Eligard® 7.5 mg): 174.0 MALIGNANT NEOPLASM OF NIPPLE AND AREOLA OF FEMALE BREAST 174.1 MALIGNANT NEOPLASM OF CENTRAL PORTION OF FEMALE BREAST 174.2 MALIGNANT NEOPLASM OF UPPER-INNER QUADRANT OF FEMALE BREAST 174.3 MALIGNANT NEOPLASM OF LOWER-INNER QUADRANT OF FEMALE BREAST 174.4 MALIGNANT NEOPLASM OF UPPER-OUTER QUADRANT OF FEMALE BREAST 174.5 MALIGNANT NEOPLASM OF LOWER-OUTER QUADRANT OF FEMALE BREAST 174.6 MALIGNANT NEOPLASM OF AXILLARY TAIL OF FEMALE BREAST 174.8 MALIGNANT NEOPLASM OF OTHER SPECIFIED SITES OF FEMALE BREAST 174.9 MALIGNANT NEOPLASM OF BREAST (FEMALE) UNSPECIFIED SITE 175.0 MALIGNANT NEOPLASM OF NIPPLE AND AREOLA OF MALE BREAST 175.9 MALIGNANT NEOPLASM OF OTHER AND UNSPECIFIED SITES OF MALE BREAST 185 MALIGNANT NEOPLASM OF PROSTATE 218.0 SUBMUCOUS LEIOMYOMA OF UTERUS 218.1 INTRAMURAL LEIOMYOMA OF UTERUS 218.2 SUBSEROUS LEIOMYOMA OF UTERUS 218.9 LEIOMYOMA OF UTERUS UNSPECIFIED 617.0 ENDOMETRIOSIS OF UTERUS 617.1 ENDOMETRIOSIS OF OVARY 617.2 ENDOMETRIOSIS OF FALLOPIAN TUBE 617.3 ENDOMETRIOSIS OF PELVIC PERITONEUM 617.4 ENDOMETRIOSIS OF RECTOVAGINAL SEPTUM AND VAGINA 617.5 ENDOMETRIOSIS OF INTESTINE 617.6 ENDOMETRIOSIS IN SCAR OF SKIN 617.8 ENDOMETRIOSIS OF OTHER SPECIFIED SITES 617.9 ENDOMETRIOSIS SITE UNSPECIFIED V10.3 PERSONAL HISTORY OF MALIGNANT NEOPLASM OF BREAST

For J9219 LEUPROLIDE ACETATE IMPLANT, 65 MG (e.g., Viadur®): 185 MALIGNANT NEOPLASM OF PROSTATE

For J9225 HISTRELIN IMPLANT, 50 MG (e.g., Vantas®)and J9226 HISTERLIN IMPLANT (SUPPRELINE LA), 50 MG: 185 MALIGNANT NEOPLASM OF PROSTATE